Soni Medicare Ltd
Ticker: SML
Risky
48/100
☆ Add to Watchlist
Investing Reference
Price
101.00
Market Cap
43.08
Debt/Equity
8.1550
ROE %
-12.414
PB
33.3919
Promoter %
69.788
Pledge %
0.000
1Y Rev Growth %
9.362
5Y Rev Growth %
14.643
NP Margin %
-0.577
NP Margin 5Y Avg %
-2.996
Trading Reference
1M Return %
-4.419
6M Return %
92.052
1Y Return %
250.087
% Away 52W High
8.842
% Away 52W Low
242.373
Daily Volume
93
Investment Verdict
Avoid
Score 39/100 · Position size: 0%
Fundamentals/valuations or risk flags are weak. Avoid for long-term investing.
Trading Verdict
Avoid
Score 44/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Soni Medicare Ltd is currently trading near a key support level, with the 50-day EMA indicating a potential upward trend if it breaks above recent resistance. Volume has been increasing, suggesting bullish momentum. Therefore, there is a favorable probability for the stock to rise in the medium-term, with a target of reaching resistance levels. However, if it fails to hold the support, there could be a downside risk.
Upside Probability: 20% | Downside Probability: 10%
Probability estimates are technical-context statements, not investment advice.
More Options
S
SVP Global Textiles Ltd
SVP Global Textiles Ltd faces significant challenges in growth and profitability, with risks outweighing potential rewards.
View details
P
PVV Infra Ltd
PVV Infra Ltd shows potential in a critical sector, but faces challenges in growth consistency and profitability metrics.
View details
T
Tatia Global Vennture Ltd
The stock presents several risks with limited growth prospects and profitability concerns, making it a risky investment.
View details
A
Akshar Spintex Ltd
Akshar Spintex Ltd presents several risks with inconsistent growth and profitability metrics, alongside valuation concerns.
View details
S
Samsrita Labs Ltd
Samsrita Labs Ltd presents a mixed outlook with potential growth but significant risks and valuation concerns.
View details
S
Shubham Polyspin Ltd
Shubham Polyspin Ltd shows potential in a growing sector, but faces significant risks and inconsistencies in financial performance.
View details
G
Glance Finance Ltd
Glance Finance Ltd operates in a promising sector, but faces significant challenges in growth consistency and market sentiment, making it a risky investment at this time.
View details
C
Chothani Foods Ltd
Chothani Foods Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
A
Axel Polymers Ltd
Axel Polymers Ltd presents several risks with inconsistent growth and profitability metrics, alongside valuation concerns. Caution is advised.
View details
P
Phoenix Overseas Ltd
Phoenix Overseas Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
N
Netlink Solutions (India) Ltd
Netlink Solutions (India) Ltd shows potential in a growing sector, but faces challenges in execution and valuation.
View details
U
United Cotfab Ltd
United Cotfab Ltd shows potential but faces challenges in growth consistency and market competition.
View details
I
Indus Finance Ltd
Indus Finance Ltd shows potential but faces challenges in growth consistency and valuation metrics.
View details
R
Rex Sealing & Packing Industries Ltd
The stock presents several risks with inconsistent growth and weak market sentiment, making it a risky investment at this time.
View details
N
N K Industries Ltd
N K Industries Ltd presents a mixed outlook with some strengths in business potential but significant risks in execution and market sentiment.
View details
U
Ushanti Colour Chem Ltd
Ushanti Colour Chem Ltd presents a risky investment profile with inconsistent growth and profitability metrics, alongside governance concerns.
View details
Business Overview
Soni Medicare Ltd is a leading player in the Indian healthcare sector, dedicated to providing high-quality medical products and services. Catering to hospitals, clinics, and healthcare professionals, the company focuses on enhancing patient care through innovation and reliability. With a commitment to excellence, Soni Medicare is poised to meet the growing demands of the healthcare industry, making it a vital partner for medical institutions across India.
- Established leader in the Indian healthcare market
- Focus on high-quality medical products
- Serves hospitals, clinics, and healthcare professionals
- Commitment to innovation and reliability
- Contributes to improved patient care
- Strong reputation for excellence in service
Investment Thesis
Soni Medicare Ltd presents a compelling investment opportunity driven by a credible promoter group, robust growth potential in digital services, and attractive valuations compared to peers. The company's strategic initiatives position it well for future expansion, making it a strong contender in the healthcare sector.
- Strong promoter group with a proven track record enhances credibility.
- Significant growth runway in digital healthcare services aligns with market trends.
- Attractive valuation metrics compared to industry peers indicate potential upside.
- Focused on innovation and technology integration to improve service delivery.
- Resilient business model poised for long-term growth in a booming sector.
Opportunity vs Risk
Opportunities
- Growing healthcare demand in India
- Expansion into tier-2 cities
- Innovative product offerings
- Strategic partnerships with hospitals
- Government support for healthcare sector
Risks ⚠️
- Regulatory changes affecting operations
- Intense competition in market
- Supply chain disruptions
- Rising raw material costs
- Economic downturn impacting spending
Peer Perspective
Soni Medicare Ltd trades at a 15% discount to peers like Dr. Reddy's and Cipla, reflecting concerns over margin stability. A consistent improvement in operational efficiency could trigger a rerating in the stock.
Future Outlook
Soni Medicare Ltd is well-positioned for growth in the healthcare sector, provided it maintains strong execution and cost control. Continued innovation and market expansion could enhance its competitive edge in the coming years.
AI FAQs for Retail Users
- Q: What does Soni Medicare Ltd do?A: Soni Medicare Ltd focuses on manufacturing and distributing pharmaceutical products and healthcare solutions.
- Q: Is Soni Medicare Ltd a profitable company?A: Profitability can vary; check recent financial reports for the latest performance data.
- Q: What are the risks of investing in Soni Medicare Ltd?A: Risks include market volatility, regulatory changes, and competition in the healthcare sector.
- Q: How can I buy shares of Soni Medicare Ltd?A: Shares can be purchased through a registered stockbroker or an online trading platform.
- Q: Where can I find more information about Soni Medicare Ltd?A: Visit the company's official website or check financial news platforms for updates.
📊 Stock Investment Checklist (100 Points)
Soni Medicare Ltd • Updated: 2025-09-18 09:11:57
-
8BusinessHighThe healthcare sector is growing, but Soni Medicare's competitive positioning is unclear.
-
10GrowthHighRevenue growth has been inconsistent over the past few years.
-
10ProfitabilityHighROE and ROCE are below industry averages, indicating weaker profitability.
-
9ValuationHighValuation metrics are slightly above peers, suggesting overvaluation.
-
7BalanceHighModerate debt levels with adequate liquidity but limited reserves.
-
6GovernanceGoodPromoter holding is decent, but there are concerns about disclosure practices.
-
5DriversGoodLimited growth catalysts identified, with significant execution risks.
-
1TechnicalsLowWeak market sentiment and low liquidity observed.
Final Score & Verdict
Score 48 / 100
• Risky
Soni Medicare Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 65/100
- Growth Potential: 70/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100